Houston, TX – 06/09/2016. DermaClip® today announced the appointment of Dr. Thomas P. Sterry, MD, FACS, to its Medical Advisory Board.
Dr. Sterry is an award winning plastic surgeon with his own private practice in Manhattan, Thomas P. Sterry, MD. He also is both a practicing member of the surgical staff and a faculty member at Mt. Sinai Medical Center, as a longtime clinical associate professor of plastic surgery. He’s certified by the American Board of Plastic Surgery (ABPS) and is a member of the American Society of Plastic Surgeons (ASPS).
His addition to the DermaClip Medical Advisory Board brings additional depth of knowledge and experience regarding skin closure and conditions for optimal cosmesis, as we move forward in introducing the DermaClip Skin Closure Device into the US market.
DermaClip® aims to optimize incision, laceration and wound repair through non-invasive, cost-effective and efficiency-producing skin closure devices. The DermaClip device is a non-invasive skin closure device that is an alternative to sutures, surgical staples and glues. The device aims to improve the patient experience while reducing the time and cost burden of closure by transforming a highly variable skill into a reproducible process. The device has been used in more than 30,000 cases, everywhere from in the field to the Emergency Department to the surgical suite. The DermaClip team believes that high quality skin closure should be available to everyone, regardless of access to high-end services. The team aims to eliminate the trade-offs in skin closure made between time of closure and quality of patient care. DermaClip is headquartered in Houston, TX. For more information, visit the DermaClip website. You can also find more about the DermaClip devices on Twitter, Facebook, LinkedIn, and Instagram.